Home/Filings/4/0001209191-22-018611
4//SEC Filing

Klein Lawrence Otto 4

Accession 0001209191-22-018611

CIK 0001674416other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 6:03 PM ET

Size

14.8 KB

Accession

0001209191-22-018611

Insider Transaction Report

Form 4
Period: 2022-03-10
Klein Lawrence Otto
Chief Business Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-03-104,5844,583 total
    Common Shares (4,584 underlying)
  • Exercise/Conversion

    Common Shares

    2022-03-11+3,00028,026 total
  • Tax Payment

    Common Shares

    2022-03-14$61.08/sh1,229$75,06726,797 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-03-113,0009,000 total
    Common Shares (3,000 underlying)
  • Exercise/Conversion

    Common Shares

    2022-03-10+4,58426,909 total
  • Tax Payment

    Common Shares

    2022-03-11$62.56/sh1,883$117,80025,026 total
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
  • [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
  • [F3]This restricted stock unit award was granted on March 10, 2020 with respect to 13,750 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023.
  • [F4]This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025.

Issuer

CRISPR Therapeutics AG

CIK 0001674416

Entity typeother

Related Parties

1
  • filerCIK 0001762583

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:03 PM ET
Size
14.8 KB